NCATS' Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs help small businesses develop and commercialize new translational technologies. Learn More.
-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- Funding & Notices
- Small Business Opportunities
Small Business Opportunities
Researchers’ Tissue Chip Model for Rare Disorders Sets Stage for Clinical Trial
Partially funded by an NCATS SBIR grant, researchers from Hesperos, Inc., created a tissue chip model that could be used to show how drugs might work for two rare neuromuscular disorders.
Apply by the Sept. 6 deadline! The SBIR & STTR Omnibus Solicitations are intended to support small business innovation research across a broad spectrum of topic areas.
Fast-track grantee Intabio signed an agreement to pair its Blaze System with the high-resolution accurate mass systems made by SCIEX, allowing them to reach a wider market and streamline biopharmaceutical development and manufacturing.
About Small Business OpportunitiesGet more details about support available to small businesses for technology development.
SBIR & STTR Research PrioritiesFind out which areas of technology development are the highest priorities for NCATS.
Small Business FundingExplore current small business funding opportunities and find information about eligibility.
Small Business ResourcesAccess more information and tools for small businesses seeking funding from NCATS.
About Small Business Opportunities
Get more details about support available to small businesses for technology development.
SBIR & STTR Research Priorities
Find out which areas of technology development are the highest priorities for NCATS.
Explore current small business funding opportunities and find information about eligibility.
Access more information and tools for small businesses seeking funding from NCATS.
Work with Us
Find out more about how NCATS can help your small business commercialize new technology.
About SBIR & STTR
The SBIR and STTR programs are government set-aside initiatives for small businesses and research organizations in the United States. These programs — in which NCATS participates alongside other NIH Institutes and Centers as well as other federal agencies — enable small businesses to engage in research and development that has the potential for commercialization and public benefit. The programs are one of the largest sources of early-stage U.S. technology financing. Learn more about these programs and others focused on small business support.
SBIR & STTR Facts
Download the SBIR & STTR fact sheet (PDF - 250KB).
Download the NCATS SBIR & STTR research priorities (PDF - 324KB)
- Funding & Notices
-